Amarin Corporation plc (AMRN)Healthcare | Drug Manufacturers - General | Dublin, Ireland | NasdaqCM
11.32 USD
-0.25
(-2.161%) ⇩
(Oct. 16, 2026, 4 p.m.
EDT)
|
Hot Take ↕ | Oct. 10, 2026, 6:45 a.m. EDT
The investment case here is severely compromised by deteriorating fundamentals and a lack of income. The company is reporting negative profit margins and a sharp contraction in revenue growth, while the balance sheet shows negative free cash flow. Crucially, the long-term price trajectory tells a stark story of destruction; despite a recent year-over-year bounce, the asset has lost over 71% of its value over the last nine years, with six of the last seven years seeing declines. This multi-year structural decline suggests the market has permanently reassessed the business quality downward. There is no dividend to provide any cushion or yield, making the stock purely a capital appreciation play on a business that is currently bleeding money. While the recent year-over-year gain offers a glimmer of hope, it does not offset the overwhelming evidence of long-term value erosion. On the short end, options flow is mixed but leans defensive, with significant put buying at lower strikes, which aligns with the weak statistical forecast. Until the revenue decline halts and turns into sustained growth, this remains a high-risk speculative vehicle rather than a viable investment. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.036426 |
| MSTL | 0.054754 |
| AutoETS | 0.056007 |
| AutoARIMA | 0.056007 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 40% |
| H-stat | 28.23 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.012 |
| Excess Kurtosis | -0.19 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 1.617 |
| Revenue per Share | 8.917 |
| Market Cap | 237,370,304 |
| Forward P/E | 11.55 |
| Beta | 0.77 |
| Profit Margins | -14.56% |
| Website | https://www.amarincorp.com |
As of Oct. 10, 2026, 6:45 a.m. EDT: Speculators are positioning defensively with heavy put volume and open interest concentrated in-the-money strikes (11.0 and 12.0), suggesting a fear of further downside. Conversely, call activity is skewed toward out-of-the-money strikes (15.0 and 19.0), indicating speculative bets on a rebound to previous highs rather than immediate near-term gains. Implied volatility is elevated on both sides, reflecting uncertainty.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.44098765 |
| Address1 | One Central Plaza |
| Address2 | 8th Floor 36 Dame Street |
| All Time High | 28,500.0 |
| All Time Low | 7.0 |
| Ask | 12.94 |
| Ask Size | 1 |
| Average Daily Volume10 Day | 74,810 |
| Average Daily Volume3 Month | 66,710 |
| Average Volume | 66,710 |
| Average Volume10Days | 74,810 |
| Beta | 0.768 |
| Bid | 9.8 |
| Bid Size | 1 |
| Book Value | 21.122 |
| City | Dublin |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | Ireland |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 11.32 |
| Current Ratio | 3.671 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,790,726,400 |
| Day High | 11.575 |
| Day Low | 11.25 |
| Debt To Equity | 1.617 |
| Display Name | Amarin |
| Dividend Yield | 0.0 |
| Earnings Call Timestamp End | 1,785,326,400 |
| Earnings Call Timestamp Start | 1,785,326,400 |
| Earnings Timestamp | 1,785,328,200 |
| Earnings Timestamp End | 1,793,190,600 |
| Earnings Timestamp Start | 1,793,190,600 |
| Ebitda | -21,095,000 |
| Ebitda Margins | -0.11327 |
| Enterprise To Ebitda | 3.241 |
| Enterprise To Revenue | -0.367 |
| Enterprise Value | -68,363,520 |
| Eps Forward | 0.98 |
| Eps Trailing Twelve Months | -1.2 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 13.4042 |
| Fifty Day Average Change | -2.0842 |
| Fifty Day Average Change Percent | -0.15548858 |
| Fifty Two Week Change Percent | -44.098766 |
| Fifty Two Week High | 20.9 |
| Fifty Two Week High Change | -9.58 |
| Fifty Two Week High Change Percent | -0.45837322 |
| Fifty Two Week Low | 11.25 |
| Fifty Two Week Low Change | 0.069999695 |
| Fifty Two Week Low Change Percent | 0.006222195 |
| Fifty Two Week Range | 11.25 - 20.9 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 733,674,600,000 |
| Float Shares | 19,412,307 |
| Forward Eps | 0.98 |
| Forward P E | 11.55102 |
| Free Cashflow | -5,569,250 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 80 |
| Fullday Change | -0.2699995 |
| Fullday Change Percent | -2.3336172 |
| Fullday Price | 11.32 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.41956002 |
| Gross Profits | 78,136,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.37186 |
| Held Percent Institutions | 0.20775 |
| Implied Shares Outstanding | 20,969,109 |
| Industry | Drug Manufacturers - General |
| Industry Disp | Drug Manufacturers - General |
| Industry Key | drug-manufacturers-general |
| Ir Website | http://investor.amarincorp.com/ |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,744,329,600 |
| Last Split Factor | 1:20 |
| Long Business Summary | Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally through wholesalers, selected regional wholesalers, and retail and mail order pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland. |
| Long Name | Amarin Corporation plc |
| Market | us_market |
| Market Cap | 237,370,304 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_407863 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -27,124,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 287,696,173 |
| Number Of Analyst Opinions | 2 |
| Open | 11.5001 |
| Operating Cashflow | 15,573,000 |
| Operating Margins | -0.28358 |
| Payout Ratio | 0.0 |
| Peg Ratio | 0.81 |
| Phone | 353 0 166 99020 |
| Previous Close | 11.57 |
| Price Hint | 2 |
| Price To Book | 0.5359341 |
| Price To Sales Trailing12 Months | 1.2745879 |
| Profit Margins | -0.14565 |
| Quick Ratio | 2.491 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.25 |
| Regular Market Change Percent | -2.16076 |
| Regular Market Day High | 11.575 |
| Regular Market Day Low | 11.25 |
| Regular Market Day Range | 11.25 - 11.575 |
| Regular Market Open | 11.5001 |
| Regular Market Previous Close | 11.57 |
| Regular Market Price | 11.32 |
| Regular Market Time | 1,792,180,801 |
| Regular Market Volume | 113,656 |
| Return On Assets | -0.023120001 |
| Return On Equity | -0.059710003 |
| Revenue Growth | -0.42 |
| Revenue Per Share | 8.917 |
| Sand P52 Week Change | 0.13723719 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 20,969,109 |
| Shares Percent Shares Out | 0.025 |
| Shares Short | 528,373 |
| Shares Short Previous Month Date | 1,788,134,400 |
| Shares Short Prior Month | 511,002 |
| Short Name | Amarin Corporation plc |
| Short Percent Of Float | 0.0255 |
| Short Ratio | 10.31 |
| Source Interval | 15 |
| Symbol | AMRN |
| Target High Price | 13.0 |
| Target Low Price | 12.0 |
| Target Mean Price | 12.5 |
| Target Median Price | 12.5 |
| Total Cash | 314,648,992 |
| Total Cash Per Share | 14.896 |
| Total Debt | 7,175,000 |
| Total Revenue | 186,232,992 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -1.2 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 14.44965 |
| Two Hundred Day Average Change | -3.12965 |
| Two Hundred Day Average Change Percent | -0.21659003 |
| Type Disp | Equity |
| Volume | 113,656 |
| Website | https://www.amarincorp.com |
| Zip | D02 K7K5 |